Cardioversion Safety − Are We Doing Enough?

There is a considerable periprocedural risk of thromboembolic events in atrial fibrillation patients undergoing cardioversion, and treatment with anticoagulants is therefore a hallmark of cardioversion safety. Based on retrospective subgroup analyses and prospective studies, non-vitamin K anticoagul...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cardiology
Auteurs principaux: Khatami, Mohsen, Pope, Marita Knudsen, Le Page, Sophie, Radic, Petra, Schirripa, Valentina, Grundvold, Irene, Atar, Dan
Format: Artigo
Langue:Inglês
Publié: S. Karger AG 2020
Sujets:
AF and Stroke: Editorial
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7677998/
https://ncbi.nlm.nih.gov/pubmed/32898849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000509343
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires